What is Freenome?
Freenome is a biotechnology company focused on early cancer detection. The company uses a multiomics approach, analyzing multiple biological data types, in combination with artificial intelligence to identify cancer in its earliest stages.
This innovative approach is designed to improve patient outcomes by facilitating timely intervention. Freenome's screening platform integrates advanced computational techniques with standard blood draws to achieve sensitive and specific detection of cancer.
Features
- Multiomics Technology: Analyzes multiple types of biological data for comprehensive cancer detection.
- Artificial Intelligence: Leverages AI to enhance detection accuracy and efficiency.
- Early Detection: Focuses on identifying cancer in its earliest, most treatable stages.
- Standard Blood Draw: Utilizes a convenient and accessible blood test for screening.
Use Cases
- Routine cancer screening
- Early detection of various cancer types
- Improving patient outcomes through timely intervention
- Clinical research and development of cancer detection tests
